Patent applications published 31 March 2010

Published: 30-Apr-2010

Patent applications taken from the weekly European Patents Bulletin


  • Methods and compsns to inhibit edema factor and adenylyl cyclase
    Mission Pharmacal Co; Board of Regents, The University of Texas System 2166841*

  • Tricyclic anilide heterocyclic CGRP receptor antagonists
    Merck Sharpe & Dohme 2166842*

  • Treatment of viral infections by modulation of host cell metabolic pathways
    The Trustees of Princeton University 2166843*

  • Reduced mass, long-acting dosage forms
    Surmondics Pharmaceuticals 2166844*

  • Alpha connexin C-terminal (ACT) peptides for treating age-related macular degeneration
    Musc Foundation for Research Development 2166845*

  • Inhibitors of janus kinases
    Merck Sharp & Dohme 2166846*

  • CETP inhibitors derived from benzoxazole arylamides
    Merck Sharp & Dohme 2166847*

  • Spiroindolines as modulators of chemokine receptors
    Glaxo Group 2166848*

  • Substituted pyrazole compounds
    Miikana Therapeutics 2166849*

  • New heterocyclic H3 antagonists
    High Point Pharmaceuticals 2166850*

  • Therapeutic pyrazoloquinoline derivatives
    Helicon Therapeutics 2166852*

  • Therapeutic pyrazolonaphthyridine derivatives
    Helicon Therapeutics 2166853*

  • Trizole derivatives for treating Alzheimer’s disease and related conditions
    Merck Sharp & Dohme 2166854*

  • Chemical compounds
    GlaxoSmithKline 2166856*

  • Kinase inhibitor compounds
    Xcovery 2166857*

  • Novel heterocyclic compounds and uses thereof
    Intra-Cellular Therapies 2166858*

  • Quinazoline salt compounds
    SmithKline Beecham 2166859*

  • Novel heterocycle compounds and uses thereof
    Intra-Cellular Therapies 2166860*

  • Agents comprising an anti-irritant active substance
    Henkel 2167030*

  • Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs
    L’urederra, Fundación Para El Desarrollo Tecnológico Y Social 2167031*

  • Pharmaceutical formulation comprising an insulin derivative
    Novo Nordisk 2167032*

  • Once daily oral dosage form comprising tacrolimus
    LifeCycle Pharma 2167033*

  • Film shreds and delivery systems incorporating same
    MonoSol 2167034*

  • Chondrocyte container and method of use
    DuPuy Mitek 2167035*

  • Compsns for delivering a drug
    Dow Corning 2167036*

  • Compsns for delivering a drug
    Dow Corning 2167037*

  • Use of TACI-IG fusion protein such as atacicept for the manufacture of a medicament to treat lupus erythematosus
    Zymogenetics 2167038*

  • Improved depot formulations
    Durect Ciorp 2167039*

  • Intranasal carbotecin formulations and methods for the treatment of autism
    MDRNA 2167040*

  • Stabilised thrombin compsns
    Zymogenetics 2167041*

  • Pharmaceutical aerosol compsns comprising fluticasone
    Generics [UK] 2167042*

  • Nutraceutical co-crystal compsns
    University of South Florida 2167043*

  • Mucoadhesive vesicles for drug delivery
    BioCure; Hirt, Thomas; Lu, Zhihua; Meier, Wolfgang; Amji, Mansoor 2167044*

  • Topical poloxamer formulations for enhancing microvascular flow; compsns and uses thereof
    University of Virginia Patent Foundation 2167045*

  • Pharmaceutical solid preparation comprising benzazepines and production method thereof
    Otsuka Pharmaceutical 2167046*

  • Process for forming solid oral dosage forms of angiotensin II receptor antagonists
    Dexcel 2167047*

  • A novel tablet dosage form
    Wockhardt Research Centre 2167048*

  • Tamper resistant lipid-based oral dosage form for opioid agonists
    Shear/Kershman Laboratories 2167049*

  • Taste masked pharmaceutical compsns of S-alkylisothiouronium derivatives
    Meditor Pharmaceuticals 2167050*

  • Biocide capsules, preparation comprising them and sanitary pad comprising the preparation
    Dolhay Klinika Egészségügyi 2167052*

  • Nanocapsules with liquid lipidic core loaded with water-soluble or water-dispersible ingredient(s)
    Universite d’Angers 2167053*

  • Method for preparing lipid nanoparticles
    Universite d’Angers 2167054*

  • Transdermal tobacco alkaloid reservoir patch
    Fertin Pharma 2167055*

  • Transdermal and transmucosal drug delivery enhancers
    Sinclair Pharmaceuticals 2167056*

  • PDE inhibitors for the treatment of hearing impairment
    Bayer Healthcare 2167057*

  • Family of PFKFR3 inhibitors with anti-neoplastic activities
    University of Louisville Research Foundation 2167058*

  • Novel prolactin compounds
    Novo Nordisk 2167059*

  • Synergistic combinations for treating hypertension
    Lycored 2167060*

  • Dermatological and cosmetic depigmenting compsns, methods for the preparation thereof and uses thereof
    Galderma Research & Development 2167061*

  • Compsns and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne
    Galderma Research & Development 2167063*

  • Compsns and methods for treating obesity and related disorders
    Vivus 2167064*

  • Combination therapy for depression
    The General Hospital Corp 2167065*

  • Droxidopa and pharmaceutical compsn thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders
    Chelsea Therapeutics 2167066*

  • Use of eflucamibe for the production for a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals
    Galderma Research & Development 2167067*

  • Anticonvulsive pharmaceutical compsns
    INSERM - Institut National de la Santé et de la Recherche Médicale 2167068*

  • Cholesterol-interacting layers phyllosilicates and methods for reducing hypercholesteremia in a mammal
    Amcol International 2167069*

  • Use of nitric oxide releasing compounds in the treatment of chronic pain
    Nicox 2167070*

  • A baclofen solution for low-volume therapeutic delivery
    Watne State University Board of Governors; Phase V Pharmaceuticals 2167071*

  • Use of olecanthal for treatment of cutaneous inflammation
    BC Developments 2167072*

  • Terpenes with antifungal activity against Malassezia yeasts
    Instituto Biomar 2167073*

  • Antibiotic compounds
    Northeastern University 2167074*

  • Mixed lineage kinases and metabolic disorders
    University of Massachusetts 2167075*

  • Hydroxyproline compsns and uses thereof
    Bergen Teknologioverforing 2167076*

  • Aryl/hetarylamides as modulators of the EP2 receptor
    Bayer Schering Pharma 2167077*

  • Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals
    Galderma Research & Development 2167078*

  • Steroid-sparing methods of treating brain oedema
    Neutron 2167079*

  • Pharmaceutical formulation comprising pramipexole
    Boehringer Ingelheim International 2167080*

  • Bactericidal anti-MRSA active pharma-ceutical compsn containing carbapenems
    Pfandler, Hans Rudolf 2167081*

  • Compsn for the treatment of metabolic disorders
    Gilead Sciences 2167082*

  • Novel 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
    DOV Pharmaceutical 2167083*

  • An allergen dosage form comprising an antihistamine
    ALK-Abelló 2167084*

  • 4-[2-(4-methylphenylsulphanyl)phenyl]piperidine for the treatment of irritable bowel syndrome (IBS)
    H Lundbeck 2167085*

  • Combination of CHL and PARP inhibitors for the treatment of cancers
    AstraZeneca 2167086*

  • New silver(1) compounds and their use in pharmaceutical compsns for the treatment, prophylaxis and prevention of infections
    CSE Incubation 2167087*

  • Therapeutic compsns and the use thereof
    Gilead Sciences 2167088*

  • Therapeutic compsns and the use thereof
    Gilead Sciences 2167089*

  • HDAC inhibitors and hormone targeted drugs for the treatment of cancer
    University of Maryland 2167090*

  • Cinnoline compounds for use in the treatment of schizophrenia
    AstraZeneca 2167091*

  • Quinazoline derivatives as P13 kinase inhibitors
    GlaxoSmithKline 2167092*

  • Pharmaceutical compsns for the treatment of chronic heart failure comprising pyrazolopyrimidine derivative compound
    Dong-A Pharmaceutical 2167093*

  • Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signalling
    Research Development Foundation 2167094*

  • Compounds for treatment
    Wista Laboratories 2167095*

  • Improving the tolerability of mirtazapine and a second active by using them in combination
    Cypress Bioscience 2167096*

  • Metal complexes incorporated within biodegradable nanoparticles and their use
    The University of Akron 2167097*

  • Allopregnanolone in a method for enhancing neurological function (Alzheimer’s disease)
    University of Southern California, Stevens Hughes Centre 2167098*

  • Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
    Vivus 2167099*

  • The redox/fyn/c-cbl pathway
    University of Rochester 2167100*

  • Antibodies and SIRNA against growth hormone, prolactin and proliferin for use in the treatment of tumours and endometriosis
    Aukland Uniservices 2167101*

  • Use of hyaluronic acid for preparing compsns particularly for improving the function of skin, eye and mucous membrane protection
    Agro Industrie Recherche et Developpements; INSERM (Institut National de la Santé et de la Recherche Médicale) 2167102*

  • Self-assembling amphiphilic polymers as anticancer agents
    Allexcel 2167103*

  • Bifunctional synthetic molecules
    BioChemicals 2167104*

  • Antimicrobial film-forming compsn, antimicrobial film, and method of verifying the presence of an antimicrobial film
    3M Innovative Properties Co 2167105*

  • Stabilised ophthalmic solutions
    Johnson & Johnson Vision Care; Collins, Gary; Mahadevan, Shivkumar; Molock, Frank 2167106*

  • Inhibitors of NCCA-ATP channels for therapy
    University of Maryland, Baltimore 2167107*

  • Skin-derived precursor cells and uses thereof
    The Hospital For Sick Children, Toronto 2167108*

You may also like